Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine Leport

Showing results (21-30 of 110) with videos related to

Pageof 11
Sort By:
Presse Medicale (Paris, France : 1983)|March 31, 2005
[Myocardial localisation of tuberculosis: the diagnostic value of cardiac MRI]Guillaume Breton, Stéphanie Leclerc, Pascale Longuet, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 19, 2013
Low alcohol consumption as a predictor of higher CD4+ cell count in HIV-treated patients: a french paradox or a proxy of healthy behaviors? The ANRS APROCO-COPILOTE CO-08 cohortMaria Patrizia Carrieri, Camelia Protopopescu, François Raffi, et al.
AIDS (London, England)|December 7, 2006
Hair versus plasma concentrations as indicator of indinavir exposure in HIV-1-infected patients treated with indinavir/ritonavir combinationXavier Duval, Gilles Peytavin, Guillaume Breton, et al.
Scandinavian Journal of Infectious Diseases|August 17, 2004
Tubulopathy consecutive to tenofovir-containing antiretroviral therapy in two patients infected with human immunodeficiency virus-1Guillaume Breton, Marina Alexandre, Xavier Duval, et al.
Journal of Empirical Research on Human Research Ethics : JERHRE|January 10, 2012
Information that should be given to HIV cohort participants during ongoing research: the viewpoints of patient representatives and research professionalsSandra Franrenet, Grégoire Moutel, François Raffi, et al.
Journal of Psychosomatic Research|November 29, 2005
Health-related quality of life and health locus of control beliefs among HIV-infected treated patientsMarie Préau, Emmanuelle Vincent, Bruno Spire, et al.
The Journal of Antimicrobial Chemotherapy|July 16, 2009
Factors associated with non-adherence to long-term highly active antiretroviral therapy: a 10 year follow-up analysis with correction for the bias induced by missing dataCamelia Protopopescu, François Raffi, Perrine Roux, et al.
Journal of Biopharmaceutical Statistics|May 6, 2003
Bivariate longitudinal model for the analysis of the evolution of HIV RNA and CD4 cell count in HIV infection taking into account left censoring of HIV RNA measuresRodolphe Thiébaut, Hélène Jacqmin-Gadda, Catherine Leport, et al.
Presse Medicale (Paris, France : 1983)|May 21, 2005
[Antiretroviral therapy for HIV-infected patients with schizophrenia. Coordinated multidisciplinary management (7 cases)]Stéphanie Leclerc, Olivier Brunschwig, Zhora Berki-Benhaddad, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 28, 2005
Response to highly active antiretroviral therapy at 6 months and long-term disease progression in HIV-1 infectionSophie Grabar, Vincent Le Moing, Cécile Goujard, et al.
Pageof 11

Showing results (21-30 of 110) with videos related to

Sort By:
Pageof 11
Presse Medicale (Paris, France : 1983)|March 31, 2005
[Myocardial localisation of tuberculosis: the diagnostic value of cardiac MRI]Guillaume Breton, Stéphanie Leclerc, Pascale Longuet, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 19, 2013
Low alcohol consumption as a predictor of higher CD4+ cell count in HIV-treated patients: a french paradox or a proxy of healthy behaviors? The ANRS APROCO-COPILOTE CO-08 cohortMaria Patrizia Carrieri, Camelia Protopopescu, François Raffi, et al.
AIDS (London, England)|December 7, 2006
Hair versus plasma concentrations as indicator of indinavir exposure in HIV-1-infected patients treated with indinavir/ritonavir combinationXavier Duval, Gilles Peytavin, Guillaume Breton, et al.
Scandinavian Journal of Infectious Diseases|August 17, 2004
Tubulopathy consecutive to tenofovir-containing antiretroviral therapy in two patients infected with human immunodeficiency virus-1Guillaume Breton, Marina Alexandre, Xavier Duval, et al.
Journal of Empirical Research on Human Research Ethics : JERHRE|January 10, 2012
Information that should be given to HIV cohort participants during ongoing research: the viewpoints of patient representatives and research professionalsSandra Franrenet, Grégoire Moutel, François Raffi, et al.
Journal of Psychosomatic Research|November 29, 2005
Health-related quality of life and health locus of control beliefs among HIV-infected treated patientsMarie Préau, Emmanuelle Vincent, Bruno Spire, et al.
The Journal of Antimicrobial Chemotherapy|July 16, 2009
Factors associated with non-adherence to long-term highly active antiretroviral therapy: a 10 year follow-up analysis with correction for the bias induced by missing dataCamelia Protopopescu, François Raffi, Perrine Roux, et al.
Journal of Biopharmaceutical Statistics|May 6, 2003
Bivariate longitudinal model for the analysis of the evolution of HIV RNA and CD4 cell count in HIV infection taking into account left censoring of HIV RNA measuresRodolphe Thiébaut, Hélène Jacqmin-Gadda, Catherine Leport, et al.
Presse Medicale (Paris, France : 1983)|May 21, 2005
[Antiretroviral therapy for HIV-infected patients with schizophrenia. Coordinated multidisciplinary management (7 cases)]Stéphanie Leclerc, Olivier Brunschwig, Zhora Berki-Benhaddad, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 28, 2005
Response to highly active antiretroviral therapy at 6 months and long-term disease progression in HIV-1 infectionSophie Grabar, Vincent Le Moing, Cécile Goujard, et al.
Pageof 11